Pancreatic Cancer Research

ResearcherHarvard UniversityNo recent work listed

Xavier Deschênes‐Simard

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4689-886X; OpenAlex author ID A5024534729. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 3

  1. Targeting ribosome biogenesis reinforces ERK-dependent senescence in pancreatic cancer. First author DOI 10.1080/15384101.2023.2278945↗
  2. Metformin turns off the metabolic switch of pancreatic cancer. Co-author DOI 10.18632/aging.102622↗
  3. Macrophages in pancreatic cancer: starting things off on the wrong track. Co-author DOI 10.1083/jcb.201307066↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gerardo Ferbeyre · 2 shared papers, 2019–2023 · strength 0.30
  2. Nabeel M. Bardeesy · 2 shared papers, 2013–2023 · strength 0.20
  3. Filippos Kottakis · 1 shared paper, 2023 · strength 0.14
  4. MC. Rowell · 1 shared paper, 2023 · strength 0.14
  5. Vikram Deshpande · 1 shared paper, 2023 · strength 0.14
  6. Benjamin Le Calvé · 1 shared paper, 2023 · strength 0.14
  7. Yusuke Mizukami · 1 shared paper, 2013 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.